Brainstorm Cell Therapeutics, Inc. (BCLI)

1.00 +0.02 (+2.04%) USD  |  OTCM  |  Aug 24, 16:00
More

Brainstorm Cell Therapeutics EPS Estimates for Current Fiscal Year

EPS Estimates for Current Fiscal Year Chart

View EPS Estimates for Current Fiscal Year for BCLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Current Fiscal Year Chart
Start Trial

Historical EPS Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
August 17, 2026 --
December 08, 2025 --
August 14, 2025 --
July 23, 2025 --
May 19, 2025 --
April 04, 2025 --
Date Value
December 12, 2024 --
October 29, 2024 --
August 14, 2024 --
July 11, 2024 --
June 11, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Fiscal Year Range, Past 5 Years

View EPS Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Current Fiscal Year Benchmarks

View EPS Estimates for Current Fiscal Year Benchmarks
Start Trial
NovelStem International Corp. Upgrade
Summit Therapeutics, Inc. Upgrade
Kezar Life Sciences, Inc. Upgrade
Protara Therapeutics, Inc. Upgrade
Clene, Inc. Upgrade

EPS Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Next Fiscal Year Upgrade